Commercial insight into the pharma and biotech sector.
Deals
Whether you are looking for in-licensing or out-licensing opportunities, need to identify potential product acquisitions arising from M&A activity or appraise growth prospects in underserved or emerging markets, we provide the data and the analytical tools you need so you can quickly find your next deal opportunity.
Download our report - DEALS TREND ANALYSIS
- Know your deal comparables in an instant
- Track & benchmark existing deals by deal value, upfront payments, royalties & co-promotion
- Find partners in your disease area with successful partnership histories
- See where Big Pharma are spending with deals by therapy areas, phase & technology
EvaluatePharma gives you unique access to:
- Unrivalled detail on company Portfolio and Product sourcing with all products classified by strategy including Organic, In-licensed, Company Acquisitions and Joint Ventures
- The largest range of searchable deal fields including Royalty Rates, Upfront Payment, Development & Sales Milestones
- Extensive detail of company acquisitions and the products sourced in acquisition
- Post deal analysis with NPV (Net Present Value) Analyzer and R&D pipeline progression